Skip to main content
. 2021 Jan 21;159(5):1913–1921. doi: 10.1016/j.chest.2021.01.026

Table 3.

Comparison of Baseline Characteristics Between Familial and Sporadic ILD Subtypes

Demographics Familial IPF (n = 134) Sporadic IPF (n =400) Familial CTD-Associated ILD (n = 18) Sporadic CTD-Associated ILD (n = 216) Familial CHP (n = 27) Sporadic CHP (n = 170) Familial uILD (n = 45) Sporadic uILD (n = 252)
Age, y 64.6 ± 10.2a 69.4 ± 9.7 67.5 ± 8.6a 56.1 ± 14.7 64.9 ± 10.1 66.5 ± 10.8 63.2 ± 10.3 66.3 ± 12.1
Male sex 91 (67.9)a 306 (76.5) 5 (27.8) 70 (32.4) 11 (40.7) 95 (55.9) 22 (48.9) 131 (52)
White race 112 (83.6) 348 (87) 15 (83.3)a 128 (59.3) 21 (77.8) 146 (85.9) 36 (80.0) 196 (77.8)
Ever smoker 76 (56.7)a 266 (67.3) 12 (66.7)a 90 (41.7) 12 (44.4) 77 (45.3) 24 (53.3) 137 (54.4)
FVC, % predicted 68.9 ± 17.7 69.5 ± 18.7 80.7 ± 17.9a 67.9 ± 20.2 61.9 ± 19.2 64.2 ± 20.4 71.3 ± 18.9 68.2 ± 21.2
Diffusion capacity, % predicted 48.5 ± 17.4 46 ± 18.6 52.7 ± 18.2 45.3 ± 17.9 46.5 ± 17.1 46.3 ± 19.1 50.9 ± 15.1 46.7 ± 19

Data are presented as No. (%) or mean ± SD. CHP = chronic hypersensitivity pneumonitis; CTD = connective tissue disease; ILD = interstitial lung disease; IPF = idiopathic pulmonary fibrosis; uILD = unclassifiable ILD.

a

P < .05 compared with the sporadic form of the disease.